Rodman David Malcom bought MLYS
February 19, 2026 · Form 4 insider transaction
Rodman David Malcom bought 51,300 shares of Mineralys Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
51,300
Price
$0.00
Total value
N/A
InsiderRodman David Malcom
Role—
SecurityStock Option
Transaction codeA: Grant or award
Transaction dateFebruary 19, 2026
Filing dateFebruary 20, 2026
Shares owned after51,300
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock option vests in monthly installments over a period of four years, with 1/48th of the total shares underlying the option vesting each one-month period following the date of grant